Drug Chatter -- Tracking biopharma stock chatter

Profile for Concert Pharmaceuticals, Inc. (CNCE)

« Back to company index

CNCE Chatter Timeline

Stock Ticker for CNCE

Most Active Tweeters for CNCE

UserTweets
@Jdalexander64 12
@mhrob 10
@1MinuteStock 5
@portefeuillefun 5
@StockTexts 4

Recent Tweets for CNCE

windham_kathryn @windham_kathryn
Lyon Street Capital Has Increased By $396,368 Its Concert Pharmaceuticals $CNCE Holding ...
January 15th 2018, 4:01pm
dispatchtribune @dispatchtribune
Concert Pharmaceuticals’ $CNCE “Buy” Rating Reiterated at Stifel Nicolaus https://t.co/vmf8taBTKW
January 15th 2018, 11:01am
OlympiaReport @OlympiaReport
Concert Pharmaceuticals’ $CNCE “Buy” Rating Reiterated at Stifel Nicolaus https://t.co/iqAOklxqjM
January 15th 2018, 11:01am
ChartMill @ChartMill
An Altman-Z score of 19.59 indicates that $CNCE is not in any danger for bankruptcy at the moment.… https://t.co/LOFs7uKqmf
January 15th 2018, 6:01am
1MinuteStock @1MinuteStock
Wondering about risks of $CNCE? The 63-day volatility is 41.27% https://t.co/WujCUb58Cg
January 15th 2018, 2:01am
WatchlistN @WatchlistN
Concert Pharmaceuticals Inc $CNCE Given Consensus Rating of “Buy” by Brokerages https://t.co/lpIMdKJ7Z0
January 14th 2018, 10:01pm
CRWECrownEquity @CRWECrownEquity
FDA Grants Fast Track Designation to $CNCE 's CTP-543 for the Treatment of Alopecia Areata https://t.co/PJIoTbup86
January 14th 2018, 10:01pm
CRWECrownEquity @CRWECrownEquity
Patent Trial and Appeal Board denies $CNCE 's petition challenging the validity of U.S. Patent No. 9,662,335 https://t.co/1Qpy5i7Jdt
January 14th 2018, 10:01pm
TranscriptDaily @TranscriptDaily
Concert Pharmaceuticals $CNCE Stock Price Down 27.2% https://t.co/6DR167yxug
January 14th 2018, 9:01am
dispatchtribune @dispatchtribune
Concert Pharmaceuticals $CNCE Stock Rating Lowered by Mizuho https://t.co/jnGqjfw0AI
January 14th 2018, 7:01am
AmericanBanking @AmericanBanking
Concert Pharmaceuticals $CNCE Given Buy Rating at Stifel Nicolaus https://t.co/2QhVsNXoY9 #stocks
January 13th 2018, 8:01pm
WeekHerald @WeekHerald
Concert Pharmaceuticals $CNCE Receives Buy Rating from Stifel Nicolaus https://t.co/tiRMxdByWt
January 13th 2018, 5:01pm
MariaDa18810214 @MariaDa18810214
Concert Pharmaceuticals, Inc. $CNCE Reaches $20.15 After 3.00% Down Move https://t.co/lm8RdQtiWX
January 13th 2018, 12:01pm
stb8444 @stb8444
$cnce I’m hoping it tanks more so I can buy a nice position, but here not trying to piss of people long it
January 13th 2018, 5:01am
ARatings @ARatings
Concert Pharma Receives a Buy from Stifel Nicolaus $CNCE https://t.co/mTVmETj066
January 13th 2018, 12:01am
WeekHerald @WeekHerald
Brokerages Set Concert Pharmaceuticals Inc $CNCE PT at $26.60 https://t.co/5yGXDcyk7K
January 12th 2018, 11:01pm
karenlevine @karenlevine
RT @Jdalexander64: $CNCE announces FDA grant of Fast Track Designation for CTP-543 in alopecia areata, a blockbuster indication. https://t…
January 12th 2018, 10:01pm
karenlevine @karenlevine
RT @Jdalexander64: If this logic is correct, $INCY has very little chance, if any at all, from stopping $CNCE from getting to market with C…
January 12th 2018, 10:01pm
1MinuteStock @1MinuteStock
Recommendation #HOLD for $CNCE with UB rating - 2.25 out of 5. https://t.co/JlHrkuMTsv
January 12th 2018, 7:01pm
MaisaCorp @MaisaCorp
$CNCE US Patent and Trademark Office turns down the drugmaker's post-grant review petition challenging the validity… https://t.co/nIPm833L1c
January 12th 2018, 5:01pm
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $CNCE for you: 93.2% https://t.co/sAp4SW3VcS
January 12th 2018, 5:01pm
noritsunagirota @noritsunagirota
Bvf Boosted Its Concert Pharmaceuticals $CNCE Position https://t.co/KBb8Vw2Ug0
January 12th 2018, 4:01pm
RSIDayTrader @RSIDayTrader
dumped $CNCE 19.64 just going for scalp +0.46
January 12th 2018, 3:01pm
newswithvalue @newswithvalue
$CNCE $INCY: Why Concert Pharmaceuticals, Inc. Is Singing the Blues Today: https://t.co/IIZoOercWV
January 12th 2018, 3:01pm
mhrob @mhrob
RT @tgtxdough: Stifel $CNCE Disappointing PTAB Decision Creates Buying Opportunity Ahead of P3 AVP-786 Results in 3Q18 PT 27 from 30
January 12th 2018, 2:01pm
Bidslookshwifty @Bidslookshwifty
@pennyflipper Bro if your not already looking $CNCE short
January 12th 2018, 2:01pm
mhrob @mhrob
RT @odibro: $CNCE FDA Grants Fast Track Designation to CTP-543 for the Treatment of Alopecia Areata
January 12th 2018, 2:01pm
mhrob @mhrob
RT @mhrob: $CNCE FDA Grants Fast Track Designation to Concert Pharmaceuticals’ CTP-543 for the Treatment of Alopecia Areata | Business Wire…
January 12th 2018, 2:01pm
mhrob @mhrob
RT @mhrob: $CNCE We remain committed to developing the first FDA-approved treatment for alopecia areata; however, we are reassessing whethe…
January 12th 2018, 2:01pm
mhrob @mhrob
RT @BDjanik: $CNCE announced that #FDA has granted Fast Track designation for CTP-543, a novel, oral #JAK inhibitor. #Stocks #Investing #B…
January 12th 2018, 2:01pm
Benzinga @Benzinga
Concert Pharma Drops On Patent Litigation Setback; Mizuho Downgrades https://t.co/53wzIk56Y5 $CNCE $INCY
January 12th 2018, 2:01pm
RSIDayTrader @RSIDayTrader
going for $CNCE scalp 19.18
January 12th 2018, 2:01pm
yoldash718 @yoldash718
$CNCE no good @skaushi https://t.co/o1QMrDJsjh
January 12th 2018, 2:01pm
ScatmanGL @ScatmanGL
RT @tgtxdough: JMP $CNCE believe investors will view today’s PTAB decision as a setback, the decision does not prevent CNCE from challengin…
January 12th 2018, 2:01pm
tgtxdough @tgtxdough
JMP $CNCE believe investors will view today’s PTAB decision as a setback, the decision does not prevent CNCE from c… https://t.co/ooMV6KDi97
January 12th 2018, 2:01pm
ProTradersNews @ProTradersNews
$CNCE $INCY: Concert Pharma Drops On Patent Litigation Setback; Mizuho …: https://t.co/hEcsalKkv5
January 12th 2018, 1:01pm
usratings @usratings
Mizuho downgrades $CNCE from Buy to Neutral, target price to $23 https://t.co/Cd5tjnnEEw
January 12th 2018, 1:01pm
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in CONCERT PHARMACEUTICALS INC. $CNCE https://t.co/PB2oc56aal https://t.co/3o9IWzs159
January 12th 2018, 1:01pm
skaushi @skaushi
$CNCE if it breaks down I see support around $17 @yoldash718 what you think?
January 12th 2018, 1:01pm
BDjanik @BDjanik
$CNCE announced that #FDA has granted Fast Track designation for CTP-543, a novel, oral #JAK inhibitor. #Stocks… https://t.co/UDuAy41rYR
January 12th 2018, 1:01pm
theflynews @theflynews
Mizuho downgrades Concert Pharmaceuticals, cites valuation, litigation overhang: https://t.co/dEy7u7r4Jq $CNCE $INCY
January 12th 2018, 12:01pm
AmericanBanking @AmericanBanking
$CNCE - Mizuho Lowers Concert Pharmaceuticals #CNCE to Neutral https://t.co/9Y0TeHdUPz
January 12th 2018, 12:01pm
ZolmaxNews @ZolmaxNews
Concert Pharmaceuticals $CNCE Downgraded by Mizuho to Neutral https://t.co/hKyfS3FXXz
January 12th 2018, 12:01pm
kjilly @kjilly
$CNCE rethinks R&D plans after loss in $INCY #patentcase #biotech #biotechnology #biopharma #patentchallenge… https://t.co/UTV8zoRh4J
January 12th 2018, 12:01pm
firsttomarkets @firsttomarkets
Concert Pharmaceuticals Inc Downgrade by Mizuho (Ranked 40th) to Neutral with $23PT $CNCE #CNCE https://t.co/UBOcb7RSXU
January 12th 2018, 12:01pm
Jdalexander64 @Jdalexander64
@Premier_Trades @karenlevine especially if $CNCE cannot be stopped by $INCY from alopecia market because it's an un… https://t.co/lm0oaEhbR9
January 12th 2018, 12:01pm
DrugPatentWatch @DrugPatentWatch
RT @hieuvnguyen: $CNCE Concert Pharma will have to pay $INCY Incyte the cost for violate the patent. Long on Incyte.
January 12th 2018, 12:01pm
monroewarriors5 @monroewarriors5
$CNCE Added at 20.3$
January 12th 2018, 12:01pm
Jdalexander64 @Jdalexander64
If this logic is correct, $INCY has very little chance, if any at all, from stopping $CNCE from getting to market w… https://t.co/x3ORznvb0j
January 12th 2018, 11:01am
portefeuillefun @portefeuillefun
Bought 200 $CNCE at $20.58, now 350 #vssporte shares.
January 12th 2018, 11:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.